The design and execution of clinical trials in cardiology adhere to rigorous scientific and ethical standards. Large-scale trials often involve collaboration between multiple research centers and may span several years to gather robust and statistically significant data. Patient recruitment, informed consent, and adherence to strict protocols are fundamental aspects of conducting ethical clinical trials. The outcomes of these trials guide healthcare professionals in making evidence-based decisions about the adoption of new therapies, shaping clinical guidelines and influencing standards of care. As technology and understanding of cardiovascular diseases advance, clinical trials play a pivotal role in translating scientific discoveries into tangible benefits for patients, fostering innovation, and continuously improving the landscape of cardiology practice.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India